State-of-the-Art BioManufacturing

universal Biotherapeutic development

Competitive and novel biologics product development and commercialization in medical areas with significant unmet medical need, across all cell-culture platforms.

Håber is building a state-of-the-art, modular, multi-product, biopharmaceutical facility. Single use bioreactors allow for flexibility and a broad portfolio approach. Aseptic fill and finish for pre-filled syringes, vials and ampules. Next generation warehousing facility hosts housing, visual inspection, auto-injector assembly, secondary packaging and serialization.

contract DEvelopment & Manufacturing

Fully-vertically integrated contract development and manufacturing services. Manufacturing scale up, production and distribution to bridge promising development programs to the population for a full range of biologic treatments

Capacity for both clinical supply and commercial scale manufacturing. Health Canada/FDA/EMA GMP standards without compromise. Fully digital end-to-end (AI-enabled) data recording and real-time quality analysis.

Flexible infrastructure & Accelerated Access

Ongoing commercial activities assure state-of-the-art infrastructure, compliance, competencies and operational experience, ready to be allocated to health or emergency response measures.

Testing: Our extensive analytical labs, equipment and data management capabilities, to be utilized for patient and population disease testing.

Therapeutics: Infrastructure, secured supply chain and vetted competencies to accelerate access to promising treatments under emergency conditions.